Evidence map›Paper›PMID 40185879›Full record

ArticleCommunications chemistry2025

Streamlined gram-scale natural N-glycan production using reversible tagging after oxidative release of natural glycans.

Qing Zhang, Yi Lasanajak, Menxin Yan, Golden Chen, Xuezheng Song

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qing ZhangDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-0203-4437
Yi LasanajakEmory Glycomics and Molecular Interactions Core, Emory University School of Medicine, Atlanta, GA, USA.
Menxin YanNatGlycan LLC, Tucker, GA, USA.
Golden ChenNatGlycan LLC, Tucker, GA, USA.
Xuezheng SongDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA. xsong2@emory.edu.ORCID http://orcid.org/0000-0003-1751-2785

Funding

Natural Glycans for Functional GlycomicsR44GM133252 · NIGMS · NATGLYCAN, LLC · PI SMITH, DAVID FLETCHER · 2020 to 2021
$1.9M
Next Generation Glycan Microarray using DNA-coded glycans and Next Generation Sequencing (NGS)R01GM137011 · NIGMS · EMORY UNIVERSITY · PI SONG, XUEZHENG · 2020 to 2023
$1.3M
NIGMS NIH HHS R01 GM137011NIGMS NIH HHS R44 GM133252U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM137011U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R44GM133252
6 · The paper itself

Abstract

The study of natural glycans is fundamental to modern glycomics; however, the functional analysis of these glycans is limited by their low natural abundance, structural heterogeneity, and the absence of efficient preparative-scale isolation methods. Here, we present a streamlined approach for the gram-scale production of complex natural N-glycans in their reducing form by combining oxidative release of natural glycans (ORNG) using household bleach, an innovative cleavable tag chemistry, and optimized multi-dimensional chromatography. Our ORNG process releases N-glycans from kilogram-scale of natural sources containing various glycoproteins, which can be efficiently attached with a 4-aminobenzoate tag, facilitating the selective separation of these glycans from other biomolecules. The tagged glycans can be purified via dry-load HILIC flash chromatography at gram scale followed by reverse-phase HPLC. Treatment with Oxone quantitatively cleaves the tag, regenerating the free reducing N-glycans in high yield. This method provides an accessible, gram-scale source of complex N-glycans, including complex asymmetric structures that are challenging to synthesize through conventional chemoenzymatic approaches. We believe this approach represents a versatile strategy for acquiring complex natural glycans, opening new avenues for the functional exploration of N-glycans in glycoscience.

Identifiers

PMID40185879
PMCPMC11971423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.